QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 8,220.00
+10.00 (0.12%)
At close: Jun 5, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 94.38 billion as of June 5, 2026.
Market Cap
94.38B
Enterprise Value
77.47B
Revenue
9.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,220.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 94.38B, a decrease of -52.80%. That is a compound annual growth rate of -79.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 94.38B | -46.62% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 129.31B |
| Cell Biotech | 111.76B |
| NovMetaPharma | 100.16B |
| Choong Ang Vaccine Laboratory | 87.87B |
| BIO-FD&C | 84.44B |
| CTCBIO | 78.30B |
| Naturalendo Tech | 75.78B |
| SunBio,Inc. | 75.72B |